MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc., (NYSE:MDT), today announced the company will host a webcast to provide an update on its CardioVascular business during the Transcatheter Cardiovascular Therapeutics (TCT) Conference on Monday, October 22, 2007 in Washington D.C. from 1 - 2 p.m. eastern time. The webcast will include a review of the Endeavor drug-eluting stent program with remarks from Medtronic senior management and time reserved for Q&A.
